As of 2025-11-09, the EV/EBITDA ratio of G1 Therapeutics Inc (GTHX) is -11.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTHX's latest enterprise value is 406.48 mil USD. GTHX's TTM EBITDA according to its financial statements is -35.15 mil USD. Dividing these 2 quantities gives us the above GTHX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 15.3x | 15.2x |
| Forward P/E multiples | 18.3x - 34.0x | 21.5x |
| Fair Price | (12.77) - (10.76) | (12.78) |
| Upside | -278.6% - -250.5% | -278.7% |
| Date | EV/EBITDA |